Navicent Health Adopts Wire-Free Radar Localization Technology to Improve the Surgical Experience for Breast Cancer Patients
Staff Report From Middle Georgia CEO
Wednesday, October 2nd, 2019
Peyton Anderson Cancer Center, Navicent Health continues to demonstrate its commitment to offering the most advanced treatment options to patients with breast cancer by becoming the first hospital in the region to adopt the SCOUT Wire-Free Radar Localization System in order to provide more compassionate care to patients undergoing treatment for breast cancer.
“Having an abnormal mammogram and having to undergo a surgical procedure can be physically and emotionally distressing, and we strive to find ways to create a better experience – and better outcomes – for our patients. SCOUT eliminates the need to place a wire inside breast tissue to locate calcifications, a mass or even a tumor. SCOUT will be used for biopsy, lumpectomy and breast conservation surgery,” said Paul Dale, M.D., Medical Director of PACC.
In over 90,000* procedures, the SCOUT system has been proven to decrease patient discomfort and improve patient satisfaction.1 SCOUT uses non-radioactive, radar technology to provide real-time surgical guidance during breast surgery, biopsy and lumpectomy. Rather than placing a wire into breast tissue to locate a tumor before a procedure, a SCOUT reflector is placed in the target tissue prior to the day of the procedure, at the patient’s convenience. During the procedure, the SCOUT guide uses real-time distance measurement guidance to accurately detect the location of the SCOUT reflector, and therefore locate the tumor to within 1mm of accuracy.
“The ability to precisely locate tumors may increase the probability of complete cancer removal and reduce the likelihood of needing follow-up surgeries – a huge advantage for early-stage breast cancer patients. In addition, the ability to strategically plan the incision may result in better cosmetic outcomes. We’re thrilled to bring this technology to central Georgia for the benefit of those addressing and surviving breast cancer,” said Tom Oliver, M.D. Chief Clinical Officer for Navicent Health.
SCOUT is also used to effectively localize lymph nodes prior to neoadjuvant therapy and can be used with any type of imaging over the course of a patient’s care.
“We’re proud to be the first in this region to adopt wire-free localization as the standard of care. As research and technology advance, we’re committed to adopting the safest and most progressive treatment options for women and men with breast cancer,” said Christa Loyd, RN, Nurse Manager for the Breast Care Center at PACC.